Therapy Areas: Inflammatory Diseases
Veeva, Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data
24 September 2020 - - US-based cloud computing company Veeva Systems (NYSE: VEEV) and Israel-based clinical research organisation Bioforum have forged collaboration with Israel-bas...
Humanigen Inks Thermo Fisher Partnership to Expand Manufacturing for COVID-19 Therapeutic Candidate Lenzilumab
24 September 2020 - - US-based clinical stage biopharmaceutical company Humanigen, Inc., (NASDAQ: HGEN) has forged a strategic collaboration with US-based life science company Thermo Fisher Scien...
NeuroRx files for FDA's EUA for RLF-100 in the treatment of patients with critical COVID-19
24 September 2020 - Drug development company NeuroRx Inc announced on Wednesday that it has filed a request for an Emergency Use Authorization (EUA) with the US FDA for the use of RLF-100 aviptadil in...
FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome
23 September 2020 - - US-based regenerative medicine company Athersys, Inc's MultiStem cell therapy was granted Regenerative Medicine Advanced Therapy designation from the US Food and Drug A...
NeuroRx submits EUA with FDA for RLF-100 (aviptadil) in the treatment of patients with critical COVID-19 and corresponding respiratory failure
23 September 2020 - Drug development company NeuroRx Inc announced on Tuesday that it has filed for an Emergency Use Authorization (EUA) with the US FDA for the use of RLF-100 (aviptadil ) in patients...
Siolta Therapeutics Raises USD 30m Series B for the Prevention and Treatment of Allergic Diseases
22 September 2020 - - US-based biotechnology company Siolta Therapeutics has raised USD 30m in a series B investment round to support the clinical development of its lead product, STMC-103H, the compa...
Related Headlines

Ampio Pharmaceuticals wins FDA IND approval for clinical trial protocol of inhaled Ampion for COVID-19 patients with respiratory distress

US FDA Grants IND, Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress

Study Finds That Children's Immune Response Protects Against COVID-19

European authority issues positive opinion for baricitinib to Eli Lilly and and Incyte

EMA recommends EU endorsement of dexamethasone for COVID-19 patients on oxygen therapy

New Study Highlights the Utility of the FebriDx Test for Rapid Triage and Identification of COVID-19

Celltrion Receives Korean MFDS Approval to Initiate Phase II/III Pivotal Trial of an Anti-COVID-19 Monoclonal Antibody Treatment Candidate, CT-P59

Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial

First Subjects Dosed in Phase 1 Clinical Trial with First Proprietary Compound, CST-2032, Targeting Neurodegenerative Disease

Exelixis, Iconic Therapeutics Tout Promising Preclinical Data That Support Best-in-Class Potential for ICON-2 in Treatment of Solid Tumors

BenevolentAI validates AI hypothesis for COVID-19 treatment under large randomised control trial

AstraZeneca's COVID-19 vaccine trial in US continues on hold until at least midweek until regulatory clearance

Humanigen's Lenzilumab Phase 3 Study in COVID-19 Recommended for Continuation by Data Safety Monitoring Board

AIDS Healthcare Foundation Calls for 100% Transparency on COVID-19 Vaccine Trials

AstraZeneca gets approval to resume trials of promising COVID-19 vaccine